Robert McCammon
University of Colorado Boulder
10 Papers
50 Citations
Robert McCammon is an academic researcher from University of Colorado Boulder. The author has contributed to research in topics: Surveillance, Epidemiology, and End Results & Radiation therapy. The author has an hindex of 7, co-authored 10 publications. Previous affiliations of Robert McCammon include Anschutz Medical Campus.
Chat about Author
Papers
Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
Robert McCammon,Tracey E. Schefter,Laurie E. Gaspar,Rebekah Zaemisch,Daniel J. Gravdahl,Brian D. Kavanagh +5 more
TL;DR: These results support the use of aggressive SBRT regimens when durable tumor control is the primary objective, and suggest a dose-control relationship within the range of SbrT doses applied.
203
Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Roshan S. Prabhu,Robert H. Press,Kirtesh R. Patel,Danielle Boselli,James T. Symanowski,Scott P. Lankford,Robert McCammon,Benjamin J. Moeller,John H. Heinzerling,Carolina E. Fasola,Anthony L. Asher,Ashley Sumrall,Zachary S. Buchwald,Walter J. Curran,Hui-Kuo Shu,Ian R. Crocker,Stuart H. Burri +16 more
TL;DR: Surgical resection with SRS may improve outcomes in patients with a limited number of large BMs compared with S RS alone, and postoperative SRS was associated with the highest rate of RN.
104
Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis
Ari Ballonoff,Kyle E. Rusthoven,Amanda L. Schwer,Robert McCammon,Brian D. Kavanagh,Michael F. Bassetti,Francis Newman,Rachel Rabinovitch +7 more
TL;DR: It is demonstrated that RT is associated with a survival advantage in patients with localized DLBCL, a benefit that extends to elderly patients, and the development of tailored therapy according to the relapse risk is warranted.
49
Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study
Amanda L. Schwer,Ari Ballonoff,Robert McCammon,Kyle E. Rusthoven,Ralph B. D'Agostino,Tracey E. Schefter +5 more
TL;DR: The results support the use of NeoRT for patients with esophageal cancer, and on multivariate analysis, NeoRT, age <65 years, adenocarcinoma histologic type, female gender, pN0 status, >10 nodes dissected, and Stage T2 disease were all independently correlated with increased OS.
47
Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
TL;DR: The cause-specific survival (CSS) and overall survival (OS) of women with T3N0M0 breast cancer in the Surveillance, Epidemiology, and End Results database after mastectomy and axillary staging from 1988 to 2002 were analyzed as discussed by the authors.
41